Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Exercise benefit to lifespan may be due to stem cell increase
Dr Mariusz Ratajczak - James Graham Brown Cancer Center, University of...
Exercise benefit to lifespan may be due to stem cell increase ( Dr Mariusz Ratajczak - James Graham Brown Cancer Center, University of Louisville, Kentucky, USA )
14 Dec 2012
Diagnosis of blood cancer after a breast cancer diagnosis
Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012
Histone deacetylases targeted as new strategy against graft versus host disease
Prof Sung Choi - University of Michigan, Ann Arbor, USA
Histone deacetylases targeted as new strategy against graft versus host disease ( Prof Sung Choi - University of Michigan, Ann Arbor, USA )
14 Dec 2012
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic...
Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
13 Dec 2012
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell...
Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
13 Dec 2012
The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab
Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston...
The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab ( Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston, USA )
13 Dec 2012
Uncovering new targets for treatment of chronic lymphocytic leukaemia
Dr John Byrd - The Ohio State University Comprehensive Cancer Center, Columbus...
Uncovering new targets for treatment of chronic lymphocytic leukaemia ( Dr John Byrd - The Ohio State University Comprehensive Cancer Center, Columbus, USA )
13 Dec 2012
Targeting the proteasome mechanism
Dr Stig Linder – Karolinska Institute, Stockholm, Sweden
Targeting the proteasome mechanism ( Dr Stig Linder – Karolinska Institute, Stockholm, Sweden )
7 Dec 2012
Effect of hypoxia on cancer progression and adaptive response
Dr Greg Semenza – John Hopkins, Baltimore, USA
Effect of hypoxia on cancer progression and adaptive response ( Dr Greg Semenza – John Hopkins, Baltimore, USA )
7 Dec 2012
New agents and mTOR inhibitors
Dr David Sabatini – Whitehead Institute, Boston, USA
New agents and mTOR inhibitors ( Dr David Sabatini – Whitehead Institute, Boston, USA )
7 Dec 2012
Transcriptional regulation of endothelial cell differentiation
Dr Elisabetta Dejana – IFOM – University of Milan, Italy
Transcriptional regulation of endothelial cell differentiation ( Dr Elisabetta Dejana – IFOM – University of Milan, Italy )
22 Nov 2012
Regulating the p53 pathway
Dr David Lane – Agency for Science, Technology and Research, Singapore
Regulating the p53 pathway ( Dr David Lane – Agency for Science, Technology and Research, Singapore )
21 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation